{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:19:45Z","timestamp":1792531185742,"version":"4.5.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8]]},"abstract":"<jats:p>Taking opioids is often accompanied by the development of dependence. Unfortunately, treatment of opioid dependence is difficult, particularly because of codependence \u2013 for example, on alcohol or other drugs of abuse. In the presented study, we analyzed the potential influence of disulfiram, a drug used to aid the management of alcoholism, on opioid abstinence syndrome, which occurs as a result of opioid withdrawal. Opioid dependence in mice was induced by subcutaneous administration of either morphine or methadone at a dose of 48\u2009mg\/kg for 10 consecutive days. To trigger a withdrawal syndrome, the opioid receptor antagonist, naloxone, was administered at a dose of 1\u2009mg\/kg (subcutaneous), and the severity of withdrawal signs was assessed individually. Interruption of chronic treatment with morphine or methadone by naloxone has led to the occurrence of opioid abstinence signs such as jumping, paw tremor, wet-dog shakes, diarrhea, teeth chattering, ptosis, and piloerection. Importantly, pretreatment with disulfiram (25, 50, and 100\u2009mg\/kg) reduced the intensity of withdrawal signs induced by naloxone in morphine or methadone-treated mice. These findings show the effectiveness of disulfiram in reducing opioid abstinence signs.<\/jats:p>","DOI":"10.1097\/fbp.0000000000000376","type":"journal-article","created":{"date-parts":[[2018,2,16]],"date-time":"2018-02-16T16:25:24Z","timestamp":1518798324000},"page":"393-399","source":"Crossref","is-referenced-by-count":9,"title":["Disulfiram attenuates morphine or methadone withdrawal syndrome in mice"],"prefix":"10.1097","volume":"29","author":[{"given":"Anna","family":"de Cord\u00e9","sequence":"first","affiliation":[{"name":"Pharmacodynamics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"Krz\u0105\u015bcik","sequence":"additional","affiliation":[{"name":"Experimental and Clinical Pharmacology, Centre for Preclinical Research and Technology, Medical University of Warsaw, Warsaw"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Woli\u0144ska","sequence":"additional","affiliation":[{"name":"Pharmacodynamics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrycja","family":"Kleczkowska","sequence":"additional","affiliation":[{"name":"Pharmacodynamics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Filip","sequence":"additional","affiliation":[{"name":"Department of Drug Addiction Pharmacology, Institute of Pharmacology, Polish Academy of Sciences, Cracow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Bujalska-Zadro\u017cny","sequence":"additional","affiliation":[{"name":"Pharmacodynamics"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230910","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000433579","article-title":"Efficacy of medications approved for the treatment of alcohol dependence and alcohol withdrawal syndrome in female patients: a descriptive review","volume":"22","author":"Agabio","year":"2016","journal-title":"Eur Addict Res"},{"key":"R2-20230910","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/ADM.0b013e3182928e02","article-title":"Effects of disulfiram on QTc interval in non-opioid-dependent and methadone-treated cocaine-dependent patients","volume":"7","author":"Atkinson","year":"2013","journal-title":"J Addict Med"},{"key":"R3-20230910","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1046\/j.1460-9568.2003.02439.x","article-title":"Increase of morphine withdrawal in mice lacking A2a receptors and no changes in CB1\/A2a double knockout mice","volume":"17","author":"Berrendero","year":"2003","journal-title":"Eur J Neurosci"},{"key":"R4-20230910","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00213-005-0139-8","article-title":"Effects of dopamine beta-hydroxylase genotype and disulfiram inhibition on catecholamine homeostasis in mice","volume":"183","author":"Bourdelat-Parks","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"R5-20230910","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.drugalcdep.2012.05.019","article-title":"Efficacy of disulfiram and twelve step facilitation in cocaine-dependent individuals maintained on methadone: a randomized placebo-controlled trial","volume":"126","author":"Carroll","year":"2012","journal-title":"Drug Alcohol Depend"},{"key":"R6-20230910","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.drugalcdep.2015.12.036","article-title":"A randomized factorial trial of disulfiram and contingency management to enhance cognitive behavioral therapy for cocaine dependence","volume":"160","author":"Carroll","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"R7-20230910","doi-asserted-by":"crossref","first-page":"6450","DOI":"10.1523\/JNEUROSCI.0491-06.2006","article-title":"Behavioral and molecular effects of dopamine D1 receptor stimulation during naloxone-precipitated morphine withdrawal","volume":"26","author":"Chartoff","year":"2006","journal-title":"J Neurosci"},{"key":"R8-20230910","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jsat.2010.09.004","article-title":"Alcohol use problem among patients in methadone maintenance treatment in Taiwan","volume":"40","author":"Chen","year":"2011","journal-title":"J Subst Abuse Treat"},{"key":"R9-20230910","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1124\/jpet.113.212357","article-title":"Effects of pharmacologic dopamine beta-hydroxylase inhibition on cocaine-induced reinstatement and dopamine neurochemistry in squirrel monkeys","volume":"350","author":"Cooper","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"R10-20230910","doi-asserted-by":"crossref","first-page":"e00393","DOI":"10.1002\/brb3.393","article-title":"Selective inhibition of dopamine-beta-hydroxylase enhances dopamine release from noradrenergic terminals in the medial prefrontal cortex","volume":"5","author":"Devoto","year":"2015","journal-title":"Brain Behav"},{"key":"R11-20230910","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1097\/01.wnr.0000180142.91644.65","article-title":"Attenuation of morphine withdrawal signs by a D1 receptor agonist in the locus coeruleus of rats","volume":"16","author":"Dizgah","year":"2005","journal-title":"Neuroreport"},{"key":"R12-20230910","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neuropharm.2013.07.007","article-title":"S-(N,N-diethylcarbamoyl)glutathione (carbamathione), a disulfiram metabolite and its effect on nucleus accumbens and prefrontal cortex dopamine, GABA, and glutamate: a microdialysis study","volume":"75","author":"Faiman","year":"2013","journal-title":"Neuropharmacology"},{"key":"R13-20230910","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0924-977X(02)00028-7","article-title":"The effect of fluvoxamine and sertraline on the opioid withdrawal syndrome: a combined in vivo cerebral microdialysis and behavioural study","volume":"12","author":"Gray","year":"2002","journal-title":"Eur Neuropsychopharmacol"},{"key":"R14-20230910","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0006-3223(03)00241-5","article-title":"Disulfiram facilitates the development and expression of locomotor sensitization to cocaine in rats","volume":"54","author":"Haile","year":"2003","journal-title":"Biol Psychiatry"},{"key":"R15-20230910","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/371155a0","article-title":"Involvement of D2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome","volume":"371","author":"Harris","year":"1994","journal-title":"Nature"},{"key":"R16-20230910","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.bbr.2009.10.032","article-title":"Disulfiram impairs the development of behavioural sensitization to the stimulant effect of ethanol","volume":"207","author":"Kim","year":"2010","journal-title":"Behav Brain Res"},{"key":"R17-20230910","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1111\/j.1360-0443.2008.02249.x","article-title":"Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV\/AIDS","volume":"103","author":"Lawrinson","year":"2008","journal-title":"Addiction"},{"key":"R18-20230910","first-page":"CD002207","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"2","author":"Mattick","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"R19-20230910","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/0006-2952(69)90150-6","article-title":"Effects of disulfiram and diethyldithiocarbamate on spontaneous locomotor activity and brain catecholamine levels in mice","volume":"18","author":"Moore","year":"1969","journal-title":"Biochem Pharmacol"},{"key":"R20-20230910","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.bbr.2014.04.007","article-title":"The role of serotonin in drug use and addiction","volume":"277","author":"Muller","year":"2015","journal-title":"Behav Brain Res"},{"key":"R21-20230910","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/npp.2008.127","article-title":"Mechanisms of withdrawal-associated increases in heroin self-administration: pharmacologic modulation of heroin vs food choice in heroin-dependent rhesus monkeys","volume":"34","author":"Negus","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"R22-20230910","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/j.1601-183X.2012.00839.x","article-title":"Modifying the role of serotonergic 5-HTTLPR and TPH2 variants on disulfiram treatment of cocaine addiction: a preliminary study","volume":"11","author":"Nielsen","year":"2012","journal-title":"Genes Brain Behav"},{"key":"R23-20230910","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.drugalcdep.2010.07.022","article-title":"Randomized, double blind, placebo-controlled trial of disulfiram for the treatment of cocaine dependence in methadone-stabilized patients","volume":"113","author":"Oliveto","year":"2011","journal-title":"Drug Alcohol Depend"},{"key":"R24-20230910","first-page":"CD007024","article-title":"Disulfiram for the treatment of cocaine dependence","volume":"1","author":"Pani","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"R25-20230910","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0091-3057(92)90451-K","article-title":"Morphine and methadone dependence in the rat: withdrawal and brain met-enkephalin levels","volume":"42","author":"Pierce","year":"1992","journal-title":"Pharmacol Biochem Behav"},{"key":"R26-20230910","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.drugalcdep.2009.04.011","article-title":"Morphine-induced physiological and behavioral responses in mice lacking G protein-coupled receptor kinase 6","volume":"104","author":"Raehal","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"R27-20230910","first-page":"25","article-title":"Alcohol use and gender effects on HIV risk behaviors in cocaine-using methadone patients","volume":"2009","author":"Rash","year":"2009","journal-title":"Neurobehav HIV Med"},{"key":"R28-20230910","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbr.2008.06.020","article-title":"Attenuation of morphine withdrawal signs by a GABAB receptor agonist in the locus coeruleus of rats","volume":"196","author":"Riahi","year":"2009","journal-title":"Behav Brain Res"},{"key":"R29-20230910","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/cns.12489","article-title":"Pharmacotherapy for alcohol dependence: the 2015 Recommendations of the French Alcohol Society, Issued in Partnership with the European Federation of Addiction Societies","volume":"22","author":"Rolland","year":"2016","journal-title":"CNS Neurosci Ther"},{"key":"R30-20230910","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neulet.2014.06.027","article-title":"The effects of a 5-HT7 receptor agonist and antagonist on morphine withdrawal syndrome in mice","volume":"578","author":"Shahidi","year":"2014","journal-title":"Neurosci Lett"},{"key":"R31-20230910","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000363232","article-title":"Alcohol use disorders in opioid maintenance therapy: prevalence, clinical correlates and treatment","volume":"21","author":"Soyka","year":"2015","journal-title":"Eur Addict Res"},{"key":"R32-20230910","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1006\/taap.1996.0147","article-title":"Disulfiram and diethyldithiocarbamate intoxication affects the storage and release of striatal dopamine","volume":"139","author":"Vaccari","year":"1996","journal-title":"Toxicol Appl Pharmacol"},{"key":"R33-20230910","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0022-3565(24)37507-X","article-title":"Differential mechanisms in the effects of disulfiram and diethyldithiocarbamate intoxication on striatal release and vesicular transport of glutamate","volume":"285","author":"Vaccari","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"R34-20230910","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pbb.2017.10.003","article-title":"Potentiation of morphine-induced antinociception and locomotion by citalopram is accompanied by anxiolytic-like effects","volume":"163","author":"Varela","year":"2017","journal-title":"Pharmacol Biochem Behav"},{"key":"R35-20230910","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0924-977X(94)00140-7","article-title":"Role of D1\/D2 dopamine and N-methyl-d-aspartate (NMDA) receptors in morphine tolerance and dependence in mice","volume":"5","author":"Verma","year":"1995","journal-title":"Eur Neuropsychopharmacol"},{"key":"R36-20230910","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejphar.2005.02.002","article-title":"Serotonin reuptake inhibitors attenuate morphine withdrawal syndrome in neonatal rats passively exposed to morphine","volume":"512","author":"Wu","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"R37-20230910","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0014-2999(99)00546-4","article-title":"Effects of GABAergic system on naloxone-induced jumping in morphine-dependent mice","volume":"381","author":"Zarrindast","year":"1999","journal-title":"Eur J Pharmacol"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00008877-201808000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:25:19Z","timestamp":1785767119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00008877-201808000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0000000000000376","relation":{},"ISSN":["0955-8810"],"issn-type":[{"value":"0955-8810","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]}}}